By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Philogen S.p.A. 

Via Bellaria, 35

Sovicille    53018  Italy
Phone: 39-0577-1781-6 Fax: 39-0577-1781-680



Company News
Philogen S.p.A. Receives Orphan Drug Designation For The Treatment Of Soft Tissue Sarcoma 10/28/2016 7:37:08 AM
Philogen S.p.A. Announces Collaboration With Johnson & Johnson Innovation (JNJ) 8/3/2016 8:10:03 AM
Philogen S.p.A. Announces Expanded Research And Development Agreement With AbbVie (ABBV) 2/15/2016 6:05:15 AM
Philogen S.p.A. Announces Exercise Of Options Within The License Agreement With Pfizer (PFE) For The Development And Potential Commercialization Of Multiple Antibody Drug Conjugates (ADCs) And Targeted Technologies 1/21/2016 10:06:05 AM
Philogen S.p.A. Announces Commencement Of Phase III Pivotal Trial In Melanoma 1/21/2016 7:20:01 AM
Actinium Pharmaceuticals, Inc. and Philogen S.p.A. Announce Start of Pre-Clinical Development of an Alpha Therapy Based Antiangiogenesis Program 11/29/2012 9:46:34 AM
Actinium Pharmaceuticals, Inc. and Philogen S.p.A. Announce Collaboration for Alpha Therapy Based Antiangiogenesis Program 8/9/2012 10:25:41 AM
Toshiba Medical Systems Corporation, Siemens (SI) and Philogen S.p.A. to Pay $7.4 Million Fine Over Italian Conspiracy Complaint 8/12/2011 8:14:29 AM
Philogen S.p.A. IPO Pulled as Bayer Corporation (BAY) Exits Cancer Pact 2/15/2011 6:37:15 AM